Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: NEBULISED DEXMEDETOMIDINE: Group ND: Will receive nebulisation with dexmedetomidine 1 mcg/kg in 4 ml of 4 % lidocaine and 10 ml NS intravenously over 10 mins.
Control Intervention1: I
Sponsors
Department of Anaesthesiology and Intensive care
Eligibility
Inclusion criteria
Inclusion criteria: ASA grade I and II
Exclusion criteria
Exclusion criteria: 1. KNOWN ALCOHOLIC OR DRUG ABUSERS 2.ALLERGY TO THE DRUGS INVOLVED IN THE STUDY 3. BRADYCARDIA , ANY TYPE OF ATRIOVENTRICULAR BLOCK 4. ANY CONTRAINDICATION FOR NASAL INTUBATION LIKE THROMBOCYTOPENIA AND COAGULOPATHIES 5. FULL STOMACH PATIENTS 6. RECENT UPPER RESPIRATORY TRACT INFECTIONS 7. ANTICIPATED DIFFICULT AIRWAY 8. PREGNANCY
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| COUGH SCORETimepoint: at 1 time point - during the passage of the ETT into the trachea | — |
Secondary
| Measure | Time frame |
|---|---|
| HEMODYNAMIC PARAMETERS:( MAP, HR and spo2)Timepoint: at baseline, after infusion of study drug and every 1 min after intubation for 5 mins;PATIENT SATISFACTION SCORETimepoint: at patient follow up after 24 hours;PHARYNGO-LARYNGEAL MORBIDITTYTimepoint: AT PATIENT FOLLOW UP AFTER 24 HOURS;POST INTUBATION SCORETimepoint: AFTER PROPER PLACEMENT OF THE ETT IN THE TRACHEA;RECALL OF THE PROCEDURETimepoint: at patient follow up after 24 hours;REQUIREMENT OF ADDITIONAL BOLUSES OF 1ML OF 2% LIGNOCAINE BY SPRAY AS YOU GO TECHNIQUETimepoint: DURING AWAKE FIBEROPTIC NASOTRACHEAL INTUBATION;SEDATION SCORETimepoint: AFTER ADMINISTRATION OF THE STUDY DRUG | — |
Countries
India
Contacts
Public ContactAnju R Bhalotra
Maulana Azad Medical College
Outcome results
None listed